-+ 0.00%
-+ 0.00%
-+ 0.00%

INMUNE BIO INC. ANNOUNCES NEW PRECLINICAL DATA AT AACR 2026 DEMONSTRATING INB03 (XPRO1595) OVERCOMES RESISTANCE AND REDUCES METASTASES IN HER2-POSITIVE BREAST CANCER MODELS

Reuters·04/16/2026 12:00:04

Please log in to view news